Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.
- DOI
- 10.1111/iju.70494
- Published
- 2026 May
- Container
- International journal of urology : official journal of the Japanese Urological Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/iju.70494,
title = {Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.},
author = {Tamura K and Matsushita Y and Watanabe H and Yanagisawa T and Mori K and Morinaka H and Bekku K and Toyoda S and Nukaya T and Maenosono R and Komura K and Araki M and Fujita K and Takahara K and Azuma H and Inamoto T},
year = {2026},
journal = {International journal of urology : official journal of the Japanese Urological Association},
doi = {10.1111/iju.70494},
url = {https://doi.org/10.1111/iju.70494}
}RIS
TY - JOUR TI - Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study. AU - Tamura K AU - Matsushita Y AU - Watanabe H AU - Yanagisawa T AU - Mori K AU - Morinaka H AU - Bekku K AU - Toyoda S AU - Nukaya T AU - Maenosono R AU - Komura K AU - Araki M AU - Fujita K AU - Takahara K AU - Azuma H AU - Inamoto T PY - 2026 JO - International journal of urology : official journal of the Japanese Urological Association DO - 10.1111/iju.70494 UR - https://doi.org/10.1111/iju.70494 ER -
APA
K, T., Y, M., H, W., T, Y., K, M., H, M., K, B., S, T., T, N., R, M., K, K., M, A., K, F., K, T., H, A., & T, I. (2026). Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.. International journal of urology : official journal of the Japanese Urological Association. https://doi.org/10.1111/iju.70494
Source records
- pubmed · retrieved 2026-09-26T09:58:51.518Z